From routine bioanalytical assays to advanced gene therapy and large-scale studies, each scientific advancement requires sophisticated tools to deliver precise and accurate results with great speed. Every study requires a partner who can incorporate the latest innovation into bioanalysis while offering guidance on fulfilling satisfactory regulations. And that’s where Bioanalytical laboratory services come into play. This need for guidance and partnership becomes even more critical for large-scale studies, particularly for smaller companies and laboratories.
Robust bioanalytical lab services can help scientists optimize drug development programs to ensure they have the required technical insights for successful bioanalytical studies. Bioanalytical assay labs can help accelerate drug development studies from routine ELISA services to complex biomarker testing. A reliable bioanalysis lab has the expertise to help with complex method development and validation for quantifying biomarkers, drugs, and metabolites in complex study matrices. This write-up will dive deep to understand the importance of bioanalysis services for large-scale studies.
Large-scale drug development studies and bioanalysis services
The pharmaceutical industry is a demanding and complex endeavor. Although researchers rapidly accumulate scientific information about drug compounds, clinical trials often require seven years. However, less than 12% of compounds entering clinical trials reach the marketing stage. Hence, expertise and knowledge for understanding the complexities are critical for increasing the chances of success. Bioanalytical lab services with robust solutions are a necessary strategic partner. They can provide systems for obtaining timely and data-driven information for directing preclinical and clinical drug development.
Drug developers partner with reliable bioanalytical laboratories to generate robust data and offer expert guidance for navigating stringent regulatory requirements. Due to exposure to a wide range of therapeutic areas and drug molecules, bioanalytical laboratories can support small and large-molecule drug development studies. Besides, such an experienced partner is critical for large-scale studies.
Must Read: ADA Assay Development: Strategies for Robust Detection of Anti-Drug Antibodies
Often, small and medium-sized drug developers and biotech companies do not have the bandwidth to conduct large-scale studies. On the other hand, they lack advanced technology and likely depend on an outsourcing partner to complete bioanalytical studies. Due to the type of work conducted regularly, bioanalytical laboratories are often well-versed with regulatory requirements and can accommodate large-scale studies and provide timely results. Nonetheless, they have an army of trained professionals and scientists to troubleshoot any issues faced during bioanalysis.
Moreover, bioanalytical laboratories are ideal for small-scale drug developers. Bioanalytical services include preclinical and clinical bioanalysis for each drug product. Their services range from discovery and preclinical assessments to clinical and post-marketing evaluations. From method development and validation to clinical sample analysis, bioanalytical laboratories offer accurate and reliable services for challenging initiatives to help researchers and drug developers make confident decisions.
Bioanalytical laboratories employ multiple technology platforms and techniques to fulfill individual customer needs. Their expertise includes non-GLP and drug discovery studies, method development, validation and transfer, clinical and preclinical assessments, PK/PD bioanalysis, BABE studies, and much more. Bioanalytical lab services have the necessary tools and expertise to support drug development and are increasingly becoming an ideal partner for accommodating large-scale studies.
